Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
McKesson
Boehringer Ingelheim
Mallinckrodt
Medtronic

Last Updated: July 3, 2022

CLINICAL TRIALS PROFILE FOR SEROQUEL XR


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Seroquel Xr

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00034905 ↗ A Comparison of Seroquel vs. Risperidone in Schizophrenia Completed AstraZeneca Phase 4 2001-07-01 The purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.
NCT00043849 ↗ Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP) Completed National Institute on Aging (NIA) Phase 4 2002-07-01 The primary aim of this study is to determine the safety and efficacy of quetiapine (Seroquel) for the treatment of psychosis and/or agitation in patients with primary dementia complicated by coexistent parkinsonism, or patients with Parkinson's disease with dementia [PDD] who have episodes of agitation or psychosis. The secondary aim is to determine the safety and tolerability, particularly the influence on parkinsonism, of quetiapine when used to treat psychosis and/or agitation in patients with dementia complicated by coexistent parkinsonism.
NCT00044655 ↗ Switching Medication to Treat Schizophrenia Completed National Institute of Mental Health (NIMH) Phase 4 2001-07-01 This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.
NCT00044655 ↗ Switching Medication to Treat Schizophrenia Completed Icahn School of Medicine at Mount Sinai Phase 4 2001-07-01 This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.
NCT00048802 ↗ Treatment and Outcome of Early Onset Bipolar Disorder Completed National Institute of Mental Health (NIMH) Phase 4 2002-08-01 This study will compare the effectiveness in the maintenance of continuing adjunctive atypical antipsychotic medication compared to traditional mood stabilizer(s) alone in the maintenance treatment of adolescents with bipolar disorder.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Seroquel Xr

Condition Name

Condition Name for Seroquel Xr
Intervention Trials
Schizophrenia 47
Bipolar Disorder 32
Major Depressive Disorder 16
Generalized Anxiety Disorder 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Seroquel Xr
Intervention Trials
Disease 61
Schizophrenia 51
Bipolar Disorder 47
Depression 42
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Seroquel Xr

Trials by Country

Trials by Country for Seroquel Xr
Location Trials
United States 763
Canada 85
Italy 44
China 35
Korea, Republic of 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Seroquel Xr
Location Trials
New York 41
California 40
Texas 37
Ohio 34
Pennsylvania 32
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Seroquel Xr

Clinical Trial Phase

Clinical Trial Phase for Seroquel Xr
Clinical Trial Phase Trials
Phase 4 73
Phase 3 62
Phase 2/Phase 3 2
[disabled in preview] 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Seroquel Xr
Clinical Trial Phase Trials
Completed 147
Terminated 21
Unknown status 13
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Seroquel Xr

Sponsor Name

Sponsor Name for Seroquel Xr
Sponsor Trials
AstraZeneca 93
National Institute on Drug Abuse (NIDA) 7
National Institute of Mental Health (NIMH) 7
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Seroquel Xr
Sponsor Trials
Other 136
Industry 115
NIH 20
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Johnson and Johnson
Merck
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.